Wenfan Luo
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation.
Journal: Clinical and molecular hepatology
Published: March 25, 2025
Indocyanine Green Clearance Test via Pulse Dye Densitometry for Portal Hypertension Diagnosis in cACLD.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 12, 2025
Lasting impacts of rapid salinity change on physiological energetics of estuarine oysters (Crassostrea hongkongensis).
Journal: Marine environmental research
Published: November 22, 2024
Identification of Clinically Significant Portal Hypertension in cACLD Individuals With Spleen Stiffness Measurement.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: October 02, 2024
Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis.
Journal: Clinical and molecular hepatology
Published: July 29, 2024
Artificial Liver Support System Improves One-Year Prognosis of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure.
Journal: Journal of gastroenterology and hepatology
Published: July 24, 2024
Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC.
Journal: Alimentary pharmacology & therapeutics
Published: October 23, 2023
Combined model with acoustic radiation force impulse to rule out high-risk varices in HBV-related cirrhosis with viral suppression.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: November 17, 2022
Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis.
Journal: Journal of hepatology
Published: April 09, 2022
Thyroid dysfunction is associated with the loss of hepatitis B surface antigen in patients with chronic hepatitis B undergoing treatment with α-interferon.
Journal: The Journal of international medical research
Published: June 29, 2021
HBsAg quantification predicts off-treatment response to interferon in chronic hepatitis B patients: a retrospective study of 250 cases.
Journal: BMC gastroenterology
Published: June 28, 2019
Last Updated: 09/26/2026